Cipla informs about press release

25 Jul 2019 Evaluate

Cipla has informed that it has enclosed press release titled 'Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI (IV Plazomicin).'.

The above information is a part of company’s filings submitted to BSE.



Cipla Share Price

1321.85 1.50 (0.11%)
30-Jan-2026 13:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1596.50
Dr. Reddys Lab 1212.35
Cipla 1321.85
Zydus Lifesciences 883.60
Lupin 2140.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×